95 related articles for article (PubMed ID: 5275017)
1. The varying dissolution rates of phenylbutazone tablets.
Thomas WH; McCarthy WB
N Z Med J; 1970 Oct; 72(461):250-3. PubMed ID: 5275017
[No Abstract] [Full Text] [Related]
2. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
[No Abstract] [Full Text] [Related]
3. Biopharmaceutical assessment of phenylbutazone and indomethacin preparations.
Turakka H; Airaksinen MM
Ann Clin Res; 1974; 6(0):suppl 11:34-43. PubMed ID: 4855463
[No Abstract] [Full Text] [Related]
4. [Biological availability and solubility of phenylbutazone].
Krówczyński L; Jachowicz R; Wajdowicz A
Folia Med Cracov; 1979; 21(1):141-7. PubMed ID: 396188
[No Abstract] [Full Text] [Related]
5. Identification of degradation products in a phenylbutazone tablet formulation.
Matsui F; Robertson DL; Poirier MA; Lovering EG
J Pharm Sci; 1980 Apr; 69(4):469-71. PubMed ID: 7373550
[TBL] [Abstract][Full Text] [Related]
6. The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.
Van Petten GR; Feng H; Withey RJ; Lettau HF
J Clin Pharmacol New Drugs; 1971; 11(3):177-86. PubMed ID: 5211351
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic studies on phenylbutazone in children.
Gladtke E
Farmaco Sci; 1968 Oct; 23(10):897-906. PubMed ID: 5712791
[No Abstract] [Full Text] [Related]
8. The physiologic availability of phenylbutazone tablets marketed in India.
Manek SP; Tipnis HP; Kulkarni RD
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):163-7. PubMed ID: 7263103
[TBL] [Abstract][Full Text] [Related]
9. Phenylbutazone.
Leeson LJ
Pharmacology; 1972; 8(1):154-63. PubMed ID: 4644645
[No Abstract] [Full Text] [Related]
10. Dissolution-dialysis method of assessing in vitro drug availability of prednisolone tablets.
Northern RE; Lach JL; Fincher JH
Am J Hosp Pharm; 1973 Jul; 30(7):622-7. PubMed ID: 4715109
[No Abstract] [Full Text] [Related]
11. Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
Bates TR; Rosenberg HA; Tembo AV
J Pharm Sci; 1973 Dec; 62(12):2057-8. PubMed ID: 4762187
[No Abstract] [Full Text] [Related]
12. Variations in theophylline, ephedrine hydrochloride and phenobarbital tablets manufactured by thirteen firms.
Lach JL; Chin TF; Parrott EL
Am J Hosp Pharm; 1972 Dec; 29(12):1043-7. PubMed ID: 4646704
[No Abstract] [Full Text] [Related]
13. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
Shaw TR; Howard MR; Hamer J
Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
[No Abstract] [Full Text] [Related]
14. [Release of drugs from tablets. I. Device estimating the release of drugs from tablets].
Czarnecki W; Nerlo H
Acta Pol Pharm; 1975; 32(2):227-32. PubMed ID: 1136833
[No Abstract] [Full Text] [Related]
15. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
Dokoumetzidis A; Macheras P
Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
[TBL] [Abstract][Full Text] [Related]
16. [Determination of butadion in tablets by spectrophotometric method].
Lirova MP; Iaskina DZ
Farmatsiia; 1969; 18(4):52-5. PubMed ID: 5379653
[No Abstract] [Full Text] [Related]
17. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets.
Otsuka M; Tomita H; Otsuka K; Kamae I; Jorgenson JA
Biomed Mater Eng; 2006; 16(2):129-35. PubMed ID: 16477121
[TBL] [Abstract][Full Text] [Related]
18. Application of Henderson equation for the determination of weakly acidic pharmaceutical compounds. Part 3: Determination of phenylbutazone.
El-Fatatry HM; Sharafel-Deen MM; Amer MM
Pharmazie; 1979; 34(3):155-7. PubMed ID: 450955
[TBL] [Abstract][Full Text] [Related]
19. Some dissolution aspects of ferrous sulfate tablets.
Blezek CE; Lach JL; Guillory JK
Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
[No Abstract] [Full Text] [Related]
20. Stability of phenylbutazone in presence of pharmaceutical colors.
Baugh R; Calvert RT; Fell JT
J Pharm Sci; 1977 May; 66(5):733-5. PubMed ID: 874762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
